Literature DB >> 19947827

Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors.

Joerg Enssle1, Grant D Trobridge, Kirsten A Keyser, Christina Ironside, Brian C Beard, Hans-Peter Kiem.   

Abstract

Lentiviral gene transfer vectors have a number of potential advantages over gammaretroviral vectors including more efficient transduction of nondividing cells, a more favorable integration site profile, and the ability to accommodate large transgenes. Here, we present long-term follow-up data of animals that received lentivirus-transduced CD34-enriched cells. Six long-term surviving dogs were available for analysis. Transgene expression was analyzed from at least 12 months to more than 5 years after transplantation in peripheral blood cells and multiple cell lineages. All animals demonstrated long-term stable transgene expression in peripheral blood myeloid, lymphoid, and red blood cells as well as in platelets. Vector integration sites were analyzed by linear amplification-mediated polymerase chain reaction and showed a polyclonal repopulation pattern in all animals. There was no evidence of any development of monoclonality or leukemia in the animals. The stable long-term multilineage transgene expression, together with detection of the same integration site in myeloid and lymphoid cells, strongly suggests the transduction of long-term repopulating stem cells. Our data demonstrate safe and efficient transduction of multilineage long-term repopulating cells with lentiviral vectors and support the use of such vectors for gene therapy studies in patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19947827      PMCID: PMC2865215          DOI: 10.1089/hum.2009.076

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  25 in total

Review 1.  Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Authors:  Christopher Baum; Christof von Kalle; Frank J T Staal; Zhixiong Li; Boris Fehse; Manfred Schmidt; Floor Weerkamp; Stefan Karlsson; Gerard Wagemaker; David A Williams
Journal:  Mol Ther       Date:  2004-01       Impact factor: 11.454

2.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Christof von Kalle; Manfred Schmidt; Françoise Le Deist; Nicolas Wulffraat; Elisabeth McIntyre; Isabelle Radford; Jean-Luc Villeval; Christopher C Fraser; Marina Cavazzana-Calvo; Alain Fischer
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

3.  Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.

Authors:  Olga S Kustikova; Bernhard Schiedlmeier; Martijn H Brugman; Maike Stahlhut; Stefan Bartels; Zhixiong Li; Christopher Baum
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

4.  Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques.

Authors:  D S An; S K Kung; A Bonifacino; R P Wersto; M E Metzger; B A Agricola; S H Mao; I S Chen; R E Donahue
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.

Authors:  P A Horn; J C Morris; A A Bukovsky; R G Andrews; L Naldini; P Kurre; H-P Kiem
Journal:  Gene Ther       Date:  2002-11       Impact factor: 5.250

6.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

Authors:  Salima Hacein-Bey-Abina; Françoise Le Deist; Frédérique Carlier; Cécile Bouneaud; Christophe Hue; Jean-Pierre De Villartay; Adrian J Thrasher; Nicolas Wulffraat; Ricardo Sorensen; Sophie Dupuis-Girod; Alain Fischer; E Graham Davies; Wietse Kuis; Lilly Leiva; Marina Cavazzana-Calvo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 7.  Gene transfer into haemopoietic cells.

Authors:  C Stocking; C Baum
Journal:  Baillieres Clin Haematol       Date:  1997-09

8.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

9.  Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol.

Authors:  Peter A Horn; Kirsten A Keyser; Laura J Peterson; Tobias Neff; Bobbie M Thomasson; Jesse Thompson; Hans-Peter Kiem
Journal:  Blood       Date:  2004-01-22       Impact factor: 22.113

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  10 in total

Review 1.  Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.

Authors:  Richard A Morgan; David Gray; Anastasia Lomova; Donald B Kohn
Journal:  Cell Stem Cell       Date:  2017-11-02       Impact factor: 24.633

2.  Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.

Authors:  Juan Fang; Eric S Jensen; Mary K Boudreaux; Lily M Du; Troy B Hawkins; Sevasti B Koukouritaki; Kenneth Cornetta; David A Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

3.  Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.

Authors:  Chang Li; Nikoletta Psatha; Pavel Sova; Sucheol Gil; Hongjie Wang; Jiho Kim; Chandana Kulkarni; Cristina Valensisi; R David Hawkins; George Stamatoyannopoulos; André Lieber
Journal:  Blood       Date:  2018-05-22       Impact factor: 22.113

Review 4.  Ex vivo gene transfer and correction for cell-based therapies.

Authors:  Luigi Naldini
Journal:  Nat Rev Genet       Date:  2011-03-29       Impact factor: 53.242

5.  Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropenia.

Authors:  Ofer Yanay; David C Dale; William R A Osborne
Journal:  Hum Gene Ther       Date:  2012-09-12       Impact factor: 5.695

6.  Intravenous injection of a foamy virus vector to correct canine SCID-X1.

Authors:  Christopher R Burtner; Brian C Beard; Douglas R Kennedy; Martin E Wohlfahrt; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Troy R Torgerson; David J Rawlings; Peter J Felsburg; Hans-Peter Kiem
Journal:  Blood       Date:  2014-03-18       Impact factor: 22.113

7.  Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.

Authors:  S Charrier; M Ferrand; M Zerbato; G Précigout; A Viornery; S Bucher-Laurent; S Benkhelifa-Ziyyat; O W Merten; J Perea; A Galy
Journal:  Gene Ther       Date:  2010-12-16       Impact factor: 5.250

8.  Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A.

Authors:  Lily M Du; Paquita Nurden; Alan T Nurden; Timothy C Nichols; Dwight A Bellinger; Eric S Jensen; Sandra L Haberichter; Elizabeth Merricks; Robin A Raymer; Juan Fang; Sevasti B Koukouritaki; Paula M Jacobi; Troy B Hawkins; Kenneth Cornetta; Qizhen Shi; David A Wilcox
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  Immunoresponse to Gene-Modified Hematopoietic Stem Cells.

Authors:  Claire M Drysdale; John F Tisdale; Naoya Uchida
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-31       Impact factor: 6.698

10.  A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.

Authors:  Elizabeth M Everson; Miles E Olzsko; David J Leap; Jonah D Hocum; Grant D Trobridge
Journal:  Mol Ther Methods Clin Dev       Date:  2016-08-17       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.